New hope for unmatched bone marrow transplant patients
This article was originally published in Scrip
Executive Summary
Only 30% of patients who need a bone marrow transplant find a matching donor within their family. Kiadis Pharma, a small Dutch biotech company, is working to improve the outcomes for these patients with its lead product, ATIR, for which it recently presented positive five-year follow-up data from a Phase I/II trial.